Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

NCT01850368 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Portal Vein Tumor Thrombus

Interventions

RADIATION: Stereotactic ablative radiotherapy

Sponsor

Korea Cancer Center Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]